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Non-alcoholic steatohepatitis (NASH) is the leading cause of chronic liver injury and the
third most common reason for liver transplantations in Western countries. It is unclear
so far how different fat sources in Western diets (WD) influence the development of
NASH. Our study investigates the impact of non-trans fat (NTF) and corn oil (Corn)
as fat source in a WD mouse model of steatohepatitis on disease development and
progression. C57BL/6J wildtype (WT) mice were fed “standard” WD (WD-Std), WD-
NTF or WD-Corn for 24 weeks. WT animals treated with WD-NTF exhibit distinct
features of the metabolic syndrome compared to WD-Std and WD-Corn. This becomes
evident by a worsened insulin resistance and elevated serum ALT, cholesterol and
triglyceride (TG) levels compared to WD-Corn. Animals fed WD-Corn on the contrary
tend to a weakened disease progression in the described parameters. After 24 weeks
feeding with WD-NTF and WD-Std, WD-Corn lead to a comparable steatohepatitis
initiation by histomorphological changes and immune cell infiltration compared to
WD-Std. Immune cell infiltration results in a significant increase in mRNA expression
of the pro-inflammatory cytokines IL-6 and TNF-α, which is more pronounced in
WD-NTF compared to WD-Std and WD-Corn. Interestingly the fat source has no
impact on the composition of accumulating fat within liver tissue as determined
by matrix-assisted laser desorption/ionization mass spectrometry imaging of multiple
lipid classes. The described effects of different fat sources on the development of
steatohepatitis finally resulted in variations in fibrosis development. Animals treated with
WD-NTF displayed massive collagen accumulation, whereas WD-Corn even seems to
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protect from extracellular matrix deposition. Noteworthy, WD-Corn provokes massive
histomorphological modifications in epididymal white adipose tissue (eWAT) and severe
accumulation of extracellular matrix which are not apparent in WD-Std and WD-
NTF treatment. Different fat sources in WD-Std contribute to strong steatohepatitis
development in WT mice after 24 weeks treatment. Surprisingly, corn oil provokes
histomorphological changes in eWAT tissue. Accordingly, both WD-NTF and WD-Corn
appear suitable as alternative dietary treatment to replace “standard” WD-Std as a
diet mouse model of steatohepatitis whereas WD-Corn leads to strong changes in
eWAT morphology.
Keywords: non-alcoholic steatohepatitis, Western diet, fatty liver, fibrosis, animal model and liver injury
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is one of the most
prevalent chronic liver diseases. It is the third most common
reason for liver transplantations in industrialized countries and
is in progress to get the second leading etiology of liver disease
(Wong et al., 2015). NAFLD is strongly associated with mortality
and encompasses a sequence of pathological changes within
the liver (Yamaguchi et al., 2007; Estes et al., 2018a; Younossi
et al., 2018a,b). These hepatic alterations in general begin with
simple steatosis and evolve to more advanced stages like Non-
alcoholic steatohepatitis (NASH), cirrhosis and end stage diseases
such as hepatocellular carcinoma (HCC) (Browning and Horton,
2004; Clark, 2006). Studies indicate that nearly 20% of the
general population in western countries suffer from fatty liver
disease and bear the risk to develop NASH (Wong et al., 2014).
Recent calculations even predict that the incidence of HCC
and NASH-related liver transplantations will increase more than
100% till 2030 (Estes et al., 2018b). As hepatic manifestation of
the metabolic syndrome NASH frequently occurs together with
obesity due to poor lifestyle and wrong dietary fat consumption,
type II diabetes, dyslipidemia but also genetic and epigenetic
factors (Rice Bradley, 2018; Schuppan et al., 2018). It is further
accompanied with insulin resistance.
On the molecular level NASH is associated with an impaired
lipid metabolism. This leads to an enhanced release of free
fatty acids (FFA) from skeletal muscle and visceral adipose
tissue leading to fat droplet accumulation in hepatocytes
(Choi and Diehl, 2008). These FFA in turn disturb de novo
lipogenesis and alter β-oxidation (Capurso and Capurso, 2012).
A low amount of dietary polyunsaturated fatty acids (PUFA),
especially n-3 PUFA but not n-6 PUFA, was shown to be
associated with the development of NAFLD including typical
features of the metabolic syndrome by regulating the expression
of transcription factors involved in fatty acids oxidation
Abbreviations: α-SMA, α-smooth muscle actin; ALT, alanine aminotransferase;
AST, aspartate aminotransferase; eWAT, epididymal white adipose tissue; FDA,
food and drug administration; FFA, free fatty acid; HCC, hepatocellular carcinoma;
HFD, high fat diet; IL-6, interleukin-6; KO, knockout; MCP-1, monocyte
chemoattractant protein-1; NAFLD, non-alcoholic fatty liver disease; NASH, non-
alcoholic steatohepatitis; NTF, non-trans fat; PUFA, polyunsaturated fatty acids;
TG, triglyceride; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis
factor-α; WD, Western diet; WT, wildtype.
(Pachikian et al., 2011). Conversely, the supplementation of n-3
PUFA leads to amelioration of hepatic steatosis (Levy et al., 2004;
Capanni et al., 2006).
Further characteristics of NAFLD activity within liver tissue
are the ballooning of hepatocytes and inflammatory cell invasion
(Kleiner et al., 2005; Hubscher, 2006). The development from
simple steatosis to steatohepatitis is further linked to oxidative
stress induced by toxic lipids and high dietary cholesterol with
an increase in inflammatory cytokine production finally leading
to the progression to fibrosis (Wouters et al., 2008, 2010; Jump
et al., 2016). At the given rise of obese patients worldwide also the
prevalence of patients developing fatty liver diseases is increasing
dramatically thus getting a global socio-economic health burden
(Agopian et al., 2012).
Up to the current moment there exists no targeted therapy
expect of changes in lifestyle to cure and prevent from NAFLD
(Neuschwander-Tetri, 2009). Since 2003 partially hydrogenated
oils or trans fats have been reported to be directly linked
to cardiovascular disease for a daily intake as little as 5 g
(Mozaffarian et al., 2006). These publications and a court process
against Kraft concerning trans fats in Oreo cookies opened
the debate how to officially handle the use of trans fats in
food industry 1. Based on this literature the Food and Drug
Administration (FDA) reacted with a labeling plan by which a
trans fat content ≥ 0.5 g has to be listed on food nutrition labels
in the same year. Already in 2003 Denmark was the first nation
worldwide widely banning trans fats leading the World Health
Organization (WHO) to establish a recommendation for a daily
limit of trans fat intake in 2004. Several big international fast-food
chains increasingly use trans fat free oil in their restaurants on a
voluntary basis.
Based in these developments we critically reconsidered the
composition of the general used WD containing trans fat
shortening as fat source leading to the development of the
metabolic syndrome and steatosis related liver damage. Our
aim was to investigate the ability and the impact of different
fat sources in WD regarding their potential to initiate diet-
induced steatohepatitis in male C57/B6J mice. In two distinct
experiments we tried to induce murine steatohepatitis by feeding
1https://www.holmesreport.com/latest/article/trans-fat-issues-generate-online-
buzz
Frontiers in Physiology | www.frontiersin.org 2 June 2019 | Volume 10 | Article 770
fphys-10-00770 June 21, 2019 Time: 16:38 # 3
Drescher et al. Western Diet Mouse Model of NASH
a trans fat-free WD (WD-NTF) and a WD containing corn oil
as fat source (WD-Corn). Surprisingly a high amount of corn
oil in WD is associated with severe histomorphological changes
in eWAT tissue and thereby exhibits the risk to cause critical
metabolic changes. Interestingly, this study further shows that
the type of fat source does not have significant influence on the
composition of fat accumulating in the liver during progression
and manifestation of steatohepatitis.
MATERIALS AND METHODS
Ethics Statement
This study was performed in strict accordance with the
recommendations of the Ethics of the regional authorities
for nature, environmental and consumer protection of North
Rhine-Westfalia (LANUV, Landesamt für Natur, Umwelt
und Verbraucherschutz NRW) Recklinghausen, Germany,
and approved by the LANUV Committee (Permit Number:
TV11018G). Further, all experiments were performed
in accordance with the German guidelines for animal
housing and husbandry.
Housing and Generation of Mice
Male wildtype mice (C57BL/6J) were purchased from Janvier
Labs, Le Genest-Saint-Isle, France. According to the EU-
Directive 2010/63 (Liedtke et al., 2013), we have tried to use
minimum numbers of animals for our animal experiments. This
Directive demands that all experiments with animals must be
performed in an ethical framework, which is based primarily
on the replacement, refinement and reduction principle (i.e., the
3R principle) and first proposed 60 years before (Russell and
Burch, 1959). In our experiments, 4 mice per group were fed
and analyzed in parallel experiments. Animals were housed in
the animal facility of the University Hospital RWTH Aachen in
12-h light/dark cycles with water and food ad libitum available.
All animals were treated in accordance with the criteria of the
German administrative panel on laboratory animal care.
WD Treatment
For dietary treatment 8–12 weeks old male C57BL/6J mice
were either fed standard Western diet (WD-Std) (40 kcal % fat
(Primex Shortening), 20 kcal % fructose, 2% cholesterol) (cat.
no. D09100301), WD with non-trans fat Primex Shortening as
fat source (WD-NTF) (40 kcal % fat (Non trans fat Primex
Shortening), 20 kcal % fructose, 2% cholesterol) (cat. no.
D16022301), WD with corn oil as fat source (WD-Corn) (40 kcal
% fat (corn oil), 20 kcal % fructose, 2% cholesterol) (cat. no.
16010101). The different diets are marked by the supplier in
different color codes (brown, white, red, and blue). All animals
were critically inspected each day to exclude differences in food
intake caused by triturating without consuming. All animals
showed a daily food intake of 5–6 g without differences between
chow and dietary treatment. To alleviate unnecessary suffering,
animals were sacrificed at the end of dietary treatment by
cervical dislocation.
Quantification and Statistics
All results were expressed as mean ± SEM and represent
data from 4 animals per group and time point. Calculations
via manual counting of positive cells were done in 10 high
power fields per liver. p-values were measured using Student’s
t-test when comparing two groups or ANOVA testing with
Tukey’s multiple comparison post-test. A value of p < 0.05 was
considered significant (∗p< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001).
Blood Collection and Serum Analytics
Blood collection was performed retro-orbital. Therefore, mice
were shortly anesthetized with isoflurane and blood was
collected via a glass capillary. Samples were centrifuged at
10,000 rpm for 5 min and serum was stored at –80◦C.
Serum transaminase levels [aspartate aminotransferase (AST)
and serum alanine aminotransferase (ALT)] were processed
by the Central Laboratory Facility (LDZ) of the University
Hospital RWTH Aachen.
NAFLD Activity Score
Histopathological scoring was done by Prof. Dr. Alain de Bruin
at the University of Utrecht via a NAFLD activity score (NAS) as
described by Kleiner et al. (2005) and Hubscher (2006).
Glucose Tolerance Test
Animals were fasted for 6 h and blood glucose was measured
every 30 min following intraperitoneal administration of 0.2 g/kg
glucose for 2 h.
Hepatic Triglycerides
Hepatic triglyceride levels were analyzed by weighing 20 mg
snap frozen liver tissue. This tissue was homogenized in 1 ml
of buffer (10 mM Tris, 2 mM EDTA, 0.25 M sucrose, pH
7.5). A standard curve was calculated in accordance with the
manufacturer’s instructions of the Instruchemie liquicolor mono
kit (InstruChemie, Delfzijl, Netherlands). 200µl of the kit reagent
were added to 2 µg of the sample or the standard solution and
incubated for 45 min at room temperature. After that the OD was
measured at 492 nm.
Histology, Sirius-Red Staining, Oil Red
O Staining
Liver samples were fixed in 4% formaldehyde, embedded in
paraffin, cut and stained with hematoxylin and eosin. Pictures
were taken using an Axio-Imager Z1 (Carl Zeiss, Jena, Germany)
for each treatment per genotype. For Sirius-red staining the
paraffin sections were incubated in a solution containing 0.1%
Sirius red and 0.1% picric acid (pH 2.0) for 1 h. After that
slides were incubated in 0.1 M HCl for 5 min, treated with
an ascending ethanol series and finally incubated and covered
in Roti-Histol (Roth, Karlsruhe, Germany). 10 images per liver
section were analyzed under polarized light. Photomicrographs
of Sirius-red positive areas taken in a 400× magnification were
analyzed via color error measurement using the open source
software Image-J. For Oil Red O staining formalin fixed frozen
liver sections were washed in PBS and stained with Oil Red O
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staining solution (Sigma-Aldrich, Taufkirchen, Germany, cat. no.
O1391). After rinsing with water counterstaining of nuclei was
performed with hematoxylin.
Immunofluorescent Stainings
Liver tissue samples conserved in OCT compound were
cut in 5-mm sections, air-dried and fixed with ice-cold 4%
paraformaldehyde. Antibodies (Supplementary Table S1) were
incubated in 1% mouse serum dissolved in PBS (PAA, Vienna,
Austria) containing 0.02% sodium acetate (Sigma-Aldrich) for
1 h at room temperature. AlexaFluor 488-conjugated or Alexa
Fluor 594-conjugated secondary antibodies (Molecular Probes,
Boston, MA, United States) were used for detection. Nuclei
were counterstained with DAPI (Vector Laboratories/Axxora,
Loerrach, Germany). Immunofluorescent signals were detected
using an AxioImager Z1 microscope (Carl Zeiss, Jena, Germany).
Images were taken in a 400× magnification. 10 photographs per
mouse liver with at least 4 mice per group were counted.
Gene Expression Analysis by Real-Time
PCR
Total mRNA was extracted from whole cryopreserved liver
tissue by using the peqGOLD RNAPureTM kit (Peqlab, Erlangen,
Germany) according to the manufacturer’s recommendations.
For cDNA synthesis 500–1,000 ng of total mRNA was first
digested with DNAse I with the DNAse I kit (Invitrogen,
Karlsruhe, Germany) and subsequently reverse-transcribed
with the Omniscript reverse-transcription kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions and used
in Real-Time PCR (Applied Biosystems, Foster City, CA). The
detection gene expression was performed by using the SybrGreen
tqPCR Supermix (Invitrogen). Primer sequences can be found
in Supplementary Table S2. The mRNA extracts from 4 mice
per group were analyzed individually. The PCR efficiencies
in our real-time PCR were evaluated by the 2−11Ct method
(Livak and Schmittgen, 2001).
Mouse Serum MultiPlex Cytokine
Measurements
Cytokines were measured in mouse sera using the chemokine 9-
Plex mouse PorcartaPlexTM bead assay (Thermo Fisher Scientific,
Schwerte, Germany) and a MAGPIX instrument using Luminex
xMAP Technology. The analysis was essentially performed
according to the manufacturer’s protocol.
Isolation of Cells and Flow Cytometry
Leukocytes were isolated from whole liver extracts. To analyze
leukocytes in whole liver extracts livers were perfused with
10 ml phosphate-buffered saline (PBS), cut up with scissors
and digested with collagenase IV (Worthington Biochemical
Corporation, Lakewood, NJ, United States) at 37◦C for 30 min.
Digested liver extracts were filtered through a 70 µm cell strainer
and cells were stained for 20 min at 4◦C with fluorochrome-
labeled monoclonal antibodies (used panel are depicted in
Supplementary Table S3). Then, cells were subjected to flow
cytometry using a BD Fortessa (BD Biosciences, Heidelberg,
Germany). Data were analyzed using FlowJo software (TreeStar,
Ashland, OR, United States).
SDS PAGE and Western Blot
Tissue of snap frozen livers was lysed in ice cold lysis buffer
(Supplementary Table S4). The protein lysat was heat
denaturated for 5 min. at 95◦C in double-strength sodium
dodecyl sulfate sample buffer containing dithiothreitol before
resolution in 10% SDS-PAGE. For primary antibody incubation
membranes were probed with anti-α-SMA (ab32575, Abcam,
Cambridge, United Kingdom), and anti-GAPDH (MCA4739,
AbD serotec, Hercules, CA, United States) antibodies. As
secondary antibodies HRP-linked anti-rabbit immunoglobulin
G (7074S, Cell signaling, Frankfurt, Germany) and HRP-linked
anti-rat (559286, BD Pharmingen, Heidelberg, Germany)
were used. The antigen-antibody complexes were visualized
using the ECL chemiluminescence kit (GE Healthcare,
Buckinghamshire, United Kingdom).
Sample Preparation for MALDI-MSI
Thin tissue sections were thawed at room temperature for 2–
3 h inside a sealed box with silica gel to avoid accumulation
of condensing water, followed by 30 min drying in a vacuum
desiccator. The analysis was performed similar to the procedure
described by Jackson et al. (2005). In detail, 20 mg/ml DHB
in 50% ethanol was directly applied as matrix substance and
deposited in 24 layers using a spray device (Suncollect sprayer,
SunChrom GmbH, Friedrichsdorf, Germany). The first layer was
deposited at 10 µl/min, the second at 20 µl/min, the third at
25 µl/min, and the following layers at 30 µl/min, with a final
amount of 140.6± 3.2 µg/cm2.
MALDI-MSI Measurement
A MALDI LTQ-Orbitrap XL hybrid mass spectrometer (Thermo
Fisher Scientific, Bremen, Germany) equipped with a nitrogen
laser (337 nm, rep. rate = 60 Hz, spot size = 80 × 120 µm) was
used for mass analysis. The instrument was externally calibrated
using commercial peptide standard mixtures (ProteoMass
calibration kit, Sigma-Aldrich) for either the normal (m/z 150–
2,000) or high (m/z 200–4,000) mass range. Xcalibur (version 2.3)
from Thermo Fisher Scientific was used for MALDI-MSI data
acquisition in positive and negative ion mode. The ion mass range
was set to 400–1,000 Da in positive ion mode and 750–2,000 in
negative ion mode, with 10 laser shots per step at laser energy
of 15 µJ. The target plate stepping distance was set to 100 µm
for both the x- and y-axes. The mass resolution was 100,000 (full
width at half maximum at m/z 400).
MALDI Data Analysis
Lipid species were assigned by comparison of the measured
molecular masses to the Lipid Metabolomics and Pathways
Strategy (MAPS) database2 and the Madison Metabolomics
Consortium Database3. For assignment, a maximum of 5 ppm
deviation between measured and theoretical mass was selected as
2http://www.lipidmaps.org/
3http://mmcd.nmrfam.wisc.edu
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FIGURE 1 | Non trans fat sources in WD cause impaired insulin resistance and increased serum parameters. (A) Total body weight curve during the 24 weeks
feeding period with Western diets containing different fat sources (WD-Std, WD-NTF, WD-Corn) (n = 4). (B) After WD treatment for 24 weeks, animals getting a
non-trans fat Western diet displayed significantly increased serum glucose levels during a glucose tolerance test for the assessment of insulin resistance (n = 4)
(∗p < 0.05). (C) Total liver weight and liver:body weight ratio of WT animals after 24 weeks WD feeding (WD-Std, WD-NTF, WD-Corn) (n = 4). (D) AST and ALT levels
in serum of WT animals after WD treatment for 24 weeks (WD-Std, WD-NTF, WD-Corn) (n = 4) (∗p < 0.05). (E) Serum cholesterol levels of WT animals after
treatment with steatosis-inducing diets (WD-Std, WD-NTF, WD-Corn) (n = 4) (∗∗p < 0.01). (F) Serum TG levels of WT animals after 24 weeks feedings Western diets
with different fat sources (WD-Std, WD-NTF, WD-Corn) (n = 4) (∗p < 0.05, ∗∗ p < 0.01).
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FIGURE 2 | MALDI FT-ICR mass spectrometry imaging of multiple lipid classes. (A–C) Representative average spectra on liver tissue of animals that received (A) the
WD-Std, (B) the WD-NTF, and (C) the WD-Corn. The low variation in relative peak intensities depicted above and below the zero line marks the low variability in the
respective groups. (D,E) Comparative analysis of the relative m/z intensities between animals receiving (D) the WD-Std and WD-NTF, or animals that received (E) the
WD-Std and WD-Corn, respectively. (F) To demonstrate the specificity of signals, the obtained m/z intensities of sections from an animal that received the WD-Std
were compared to the 2,5-DHAP matrix background. Each average spectrum represents one animal measured by MALDI FT-ICR mass spectrometry imaging in
positive ion mode.
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FIGURE 3 | Comparison of individual lipid concentration and distribution by high resolution mass spectrometry imaging. Lipid composition in the liver of animals
receiving the WD-Std, WD-NTF or WD-Corn compositions were assessed by mass spectrometry imaging (n = 4). Exemplary images of panel (A)
phosphatidylcholine 36:4 (PC(36:4)) and (B) TG 56:5 (TG(56:5)) and corresponding quantified signal intensities of panel (C) PC(36:4) and (D) TG(56:5) are shown.
Among all observed lipid species, no significantly different accumulation was found.
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FIGURE 4 | Continued
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FIGURE 4 | Differences in fat deposition and immune cell infiltration in Western diets with varying fat sources. (A) Representative H&E stained liver sections of WT
animals after 24 weeks treatment with different Western style diets (WD-Std, WD-NTF, WD-Corn). (B) No differences in the NAFLD activity score (NAS) between WD
with different fat sources. The used NAS considers steatosis, lobular inflammation and hepatocellular ballooning. Biopsies with a score < 3 were diagnosed “not
NASH.” The histopathological validation was performed by Prof. Alain de Bruin at the University of Utrecht. (C) Flow cytometric analysis of CD11b+ cell subsets
(CD11b+/F4/80+) after 24 weeks WD treatment. Cells were gated by FSC/SSC, duplets were excluded. Live/CD45+, CD11b+, CD11b+/F4/80+ (regarded as
macrophages), CD62L+ (neutrophil infiltration and activation marker) (n = 4) (∗p < 0.05, ∗∗∗ p < 0.001). (D) Intrahepatic CD4+ and CD8+ T cells were analyzed by
Flow Cytometry after feeding Western diets with different fat sources for 24 weeks. CD4+ and CD8+ T cells were gated by FSC/SSC, duplets were excluded,
Live/CD45+, CD4+ or CD8+. A statistical analysis of the ratio of CD4+/CD8+ T cells of recorded cells was performed. Further CD4+ T cell subsets were gated via
CD4+/CD25+ (regarded as regulatory T cells) (n = 4) (∗p < 0.05). (E) Statistical analysis of the percentage of F4/80+ cells on stained liver sections of WT mice after
24 weeks treatment with different WDs. 10 view fields/liver of n = 4 animals per genotype and time point were included (Scale bars: 100 µm, Magnification: 200×)
(∗p < 0.05, ∗∗ p < 0.01). (F) Statistical analysis of the percentage of Ly6G+ cells on stained liver sections of WT mice after 24 weeks treatment with different WDs.
10 view fields/liver of n = 4 animals per genotype and time point were included (Scale bars: 100 µm, Magnification: 200×).
the tolerance window. Due to the presence of salts in biological
tissues, mass spectra will contain adducts of cationic salts, such
as sodium or potassium apart from the protonated molecular
ion [M+H]. Images and statistical analysis were carried out
with SCiLS software lab 2018b (SCiLS, Bremen, Germany). First,
raw data were converted to a suitable format for SCiLS, and
normalized using the total ion count (TIC). The region of
interest (ROI) where selected in the Nissl staining. A receiver-
operator characteristic (ROC) analysis was done on each ROI,
to statistically analyze m/z values that were either increased or
decreased in the livers with different diets. The ROC analysis
results were analyzed with Kruskal–Wallis test to find m/z
values that were consistently statistically significant, in each
ROI, across all datasets. Distribution maps of these selected m/z
values were generated using SCiLS, with edge-preserving weak
image denoising.
RESULTS
Different Fat Sources in Western Diet
Show Adverse Effects on the Outcome of
the Metabolic Syndrome in Mice
The development of steatosis under WD-Std treatment is in part
dependent on a high amount of fat within the diet. In a second
experimental setup, we next aimed to analyze whether the source
of fat within the WD influences the outcome of the metabolic
syndrome and disease progression. Twelve weeks old WT mice
(25 g) were fed standard WD (WD-Std), WD with a non-trans
fat source (WD-NTF) and WD with corn oil as fat source (WD-
Corn) for 24 weeks ad libitum that are marked by the supplier in
a different color code (i.e., white, red, and blue) (Supplementary
Figures S1–S3). Interestingly, mice fed with a WD containing
corn oil as fat source trended to gain less weight over a 24 weeks
treatment period (Figure 1A), while having the same food
intake compared to the other groups (WD-Std, WD-NTF). The
investigation of glucose tolerance revealed ameliorated glucose
tolerance in the WD-Corn group, while WD-NTF treatment led
to higher serum glucose levels over time (Figure 1B). In contrast,
measurement of the total liver weight and a calculation of the
liver:body weight ratio showed no differences between groups
(WD-Std, WD-NTF, WD-Corn) (Figure 1C). Analysis of serum
transaminases unexpectedly showed decreased AST and ALT
levels in mice fed with WD-Corn compared to the other groups
(Figure 1D). Further treatment with WD-Corn lead to dropped
cholesterol and TG levels in serum compared to WD-Std and
WD-NTF (Figures 1E,F).
The Type of Fat Source Does Not
Influence the Type of Fat Accumulating
in Liver Tissue in WD-Induced Steatosis
Next, we addressed the question whether WD treatment with
different fat sources influences the composition of the fat
accumulating in liver tissue during steatosis development.
Therefore, we performed high-resolution matrix-associated laser
desorption/ionization mass spectrometry imaging on liver
specimens of mice fed with respective diets. Using this imaging
technique, we were able to identify and classify the spatial
distribution of thousands of lipids within the liver tissues. In
regard to reproducibility, the molecules and their concentrations
within the animals of the different groups were highly
reproducible (Figures 2A–C). In addition, when comparing
animals fed with different WD diets, the overall signals were
the same (Figures 2D,E). The identified lipid signals during
imaging were highly specific and not influenced by the 2,5-
Dihydroxyacetophenone (DHAP) used as matrix (Figure 2F).
Also, when we imaged individual classes of lipids in more
detail, we found that the overall concentrations of defined lipids
were the same in the different groups receiving different WDs
(Figure 3 and Supplementary Figure S4).
Different Fat Sources Lead to Altered
Expression of Steatohepatitis and
Fibrosis
Twenty-four weeks WD treatment with different fat sources
lead to strong liver injury shown by hepatocyte ballooning
and massive fatty liver degeneration with fine and coarse fat
droplet formation, getting evident in the hematoxylin and eosin
(H&E) and Oil Red staining and in the direct measurement of
intrahepatic TG (Figure 4A and Supplementary Figure S5). The
histological scoring by the calculation of a NAFLD activity score
(NAS) supports these findings (Figure 4B and Supplementary
Figure S6). Invasive fat accumulation further provoked strong
immune cell infiltration and subsequent inflammation in WD
fed mice. Unexpectedly, the overall number of CD45+ cells
was significantly decreased in mice fed with WD containing
corn oil (Figure 4C). Analysis of myeloid derived immune cell
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FIGURE 5 | Earlier and stronger fibrosis development in WT animals fed with Western diet containing non-trans fat shortening as fat source. (A) mRNA expression
levels of IL-6 and TNF-α. Whole liver homogenates of WT animals after 24 weeks treatment with Western diets containing different fat sources (WD-Std, WD-NTF,
WD-Corn) were analyzed via real-time PCR. 4 animals per group were included (∗p < 0.05). (B) Analysis of mRNA expression levels of collagen1α and α-SMA in
whole liver homogenates. WT mice were fed WD (WD-Std, WD-NTF, WD-Corn) for 24 weeks. mRNA expression was analyzed via real-time PCR. 4 animals per
group were included. (C) Representative Sirius Red stained liver sections of WT animals fed with steatosis inducing Western diets (WD-Std, WD-NTF, WD-Corn).
(D) Quantitative evaluation of Sirius Red stained liver sections of WD treated animals (n = 4) (∗p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001). (E) α-SMA Western Blot
analysis from whole liver extract of WT mice after treatment with WDs containing different fat sources (WD-Std, WD-NTF, WD-Corn). GAPDH serves as
housekeeping protein. (F) Quantitative evaluation of α-SMA Western Blot analysis normalized to GAPDH expression levels. Analysis reveal a significant increase in
protein levels of α-SMA in mice fed with WD containing non-trans fat shortening as fat source (n = 4) (∗∗p < 0.01).
subpopulations interestingly showed no significant differences
in the amount of CD11b+/F480+ cells between treatment
groups (for representative gating see Supplementary Figure
S7A). The observed decrease was then reflected in CD62L+ cell
populations. Next, we assessed hepatic infiltration of lymphoid
immune cell subpopulations (Figure 4D) (for gating strategy see
Supplementary Figure S7B). No differences between treatment
groups were observed regarding the amount of CD4+ or CD8+
cells, but the calculation of the CD4/CD8 T cell ratio in
the liver showed a shift to a more dominant CD4 related T
cell response in mice fed with WD-NTF and WD-Corn. To
elucidate these differences further, these CD4+ T cells were
characterized in more detail. A significant increase in the amount
of CD4+/CD25+ cells was evident in WD-NTF fed animals.
The disparity of immune cell infiltration between the different
treatments was studied further. Therefore, we performed
immunofluorescent stainings for F4/80 and Ly6G/C to receive
an impression of the distribution of F4/80+ cells (regarded
as macrophages) and Ly6G/C+ cells (regarded as neutrophils).
24 weeks feeding with WD-NTF and WD-Corn led to an increase
in F4/80+ cells (Figure 4E and Supplementary Figure S8A).
This increase was clearly more pronounced in animals fed
with WD-Corn compared to the other groups (WD-Std, WD-
NTF). Conversely, Ly6G+ cells show a strong tendency to be
increased in livers of animals receiving WD-NTF while mice
fed WD-Corn display decreased levels compared to WD-Std
and WD-NTF (Figure 4F and Supplementary Figure S8B). To
specifically investigate whether these infiltrating cells contribute
to a more pro-or anti-inflammatory microenvironment we
performed mRNA expression analysis of different cytokines.
Interestingly, experiments reveal an increased expression of
the pro-inflammatory cytokines interleukin-6 (IL-6), TNF-α,
MCP-1 and interleukin-18 (IL-18) in mice fed with WD-NTF
(Figure 5A and Supplementary Figures S9A,B). Apart from
that, WD-Std and WD-Corn fed animals exhibited similar
results, although still elevated compared to normal chow fed
WT animals, or even display a drop in cytokine expression
(MCP-1, IL-18). This leads to the conclusion that WD-Std and
WD-Corn display a comparable development and progression
of diet-induced chronic liver injury whereas treatment with
WD-NTF provokes a more pro-inflammatory milieu within the
liver thereby resulting in more pronounced steatohepatitis. This
observation can be corroborated when assessing the progression
from simple fatty liver degeneration to fibrosis initiation by
extracellular matrix accumulation as a result of hepatic stellate
cell activation and transdifferentiation. All dietary treatments
lead to elevated mRNA expression of collagen 1α and α-SMA,
which is a hallmark of hepatic fibrogenesis and majorly driven by
activated and transdifferentiated hepatic stellate cells (Figure 5B).
Animals after 24 weeks treatment with WD-NTF thereby
show a trend to stronger expression of these genes compared
to WD-Std and WD-Corn fed mice. Next, a Sirius Red staining
was performed. This staining and the quantitative calculation of
Sirius Red positive fibers demonstrate an escalation in fibrosis
development in animals exposed to WD-NTF for 24 weeks
(Figures 5C,D). Although the amount of the Sirius Red positive
area also increases in mice fed WD for 24 weeks, these
changes were more pronounced in WD-NTF treated animals.
Surprisingly, WD-Corn did not lead to intrahepatic extracellular
matrix deposition. These findings were further confirmed by the
results of α-SMA Western Blot analysis which indicate stronger
activation of hepatic stellate cells (Figures 5E,F).
Treatment With Different Western Diets
Is Associated With Diverse Inflammatory
Conditions in eWAT
Western diets treatment leads to a significant increase in eWAT
weight. The promoting influence of inflamed eWAT on NASH
progression was described by Mulder et al. (2016). Thus, we
next wanted to investigate whether the inflammatory differences
observed in the liver upon treatment with different WDs is
reflected in eWAT. Interestingly, total eWAT weight and the
eWAT:body weight ratio were decreased in WD-NTF and WD-
Corn compared to WD-Std (Figures 6A,B). In the course of this
WD-Corn treated animals show the strongest drop in eWAT
weight. Surprisingly, H&E and Sirius Red staining reveal that this
is exactly the dietary treatment leading to immune cell infiltration
and fibrosis development in animals after 24 weeks which does
not become present in mice fed with WD-Std or WD-NTF
(Figures 6C,D). Subsequent, flow cytometric analysis support
these findings showing a trend to an increased cell infiltration
of CD11b+/Ly6G+ and CD4+ cells in this group (Figure 6E).
Consistent with the Sirius Red staining, mRNA expression of
the fibrosis markers collagen 1α and α-SMA were overexpressed
in mice after WD-Corn feeding (Figure 6F). These results
suggest a great impact of corn oil on eWAT metabolism thereby
maybe influencing steatosis and steatohepatitis development and
progression in a positive way.
To get further insight into inflammatory changes, which may
be associated with the diverse conditions in eWAT, the protein
quantities of leptin and adiponectin were measured in serum,
liver and eWAT directly. Interestingly, WT animals treated
with different WDs (WD-Std, WD-NTF, WD-Corn) showed
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FIGURE 6 | More pronounced fibrosis progression in eWAT of mice treated with WD containing corn oil. (A) Total eWAT weight and (B) eWAT:body weight ratio
drops in WT animals fed a WD-NTF compared to standard WD-Std and WD-Corn after 24 weeks treatment (n = 4) (∗p < 0.05, ∗∗ p < 0.01). (C) Representative H&E
stained eWAT sections of WT animals after 24 weeks treatment with different Western style diets (WD-Std, WD-NTF, WD-Corn). (D) Representative images of Sirius
Red stained eWAT sections from WD fed WT animals (WD-Std, WD-NTF, WD-Corn). (E) Flow Cytometric analysis of eWAT infiltrating immune cells. Cells were gated
via FSC/SSC, duplets were excluded. Live/CD45+, CD11b+/F4/80+ (regarded as macrophages) or CD11b+/Ly6G+ (regarded as neutrophils), CD4+ or CD8+
(n = 4) (∗p < 0.05). (F) mRNA expression levels of Collagen1α and α-SMA in whole eWAT homogenates. WT mice were fed WD (WD-Std, WD-NTF, WD-Corn) for
24 weeks. mRNA expression was analyzed via real-time PCR. 4 animals per group were included.
no differences in their leptin levels in serum and in the liver
(Supplementary Figures S10A,B). At the same time eWAT
leptin levels were significantly reduced in animals fed with WD-
NTF (Supplementary Figure S10C). Adiponectin serum levels
show a slight increase in animals fed with WT-Corn but do not
change in the liver (Supplementary Figures S10D,E). eWAT on
the contrary showed increased adiponectin levels in WT mice
treated with WD-Corn (Supplementary Figure S10F).
DISCUSSION
Excessive intake of trans fats or industrially manufactured
PUFA bears the risk to develop metabolic disorders such
as obesity, which further lead to cardiovascular and hepatic
diseases through promoting inflammation and oxidative stress
(Monguchi et al., 2017). The mechanisms how the intake of
industrially manufactured PUFA (trans fats) initiates metabolic
disorders is well investigated. Recent studies describe a direct
association between high serum levels of trans fatty acids and
insulin resistance and the body weight composition in diabetic
patients especially in the United States (Santos et al., 2013; Liu
et al., 2018). In line with these results we found that feeding a
trans fat containing WD to WT mice leads to an increase in body
weight, an altered insulin resistance and other typical features
of the metabolic syndrome finally leading to the development of
NASH (Figure 1). Banning of theses trans fat supplementation
to food products under which also the widely used Western diet
(WD-Std) as animal model for steatohepatitis is affected lead us to
critically reconsider this diet as appropriate model to mimic the
human disease pathogenesis. Therefore, the aim of the present
study was to evaluate the impact of different fat sources such
as a NTF shortening and corn oil as supplementation to a high
fat diet (HFD) to replace trans fats in the WD mouse model of
steatohepatitis.
A variety of experiments in different rodent animal models
showed that feeding a HFD containing different amounts of
the most common PUFA n-3, n-6 and n-9 of natural origin
modulate the inflammatory cytokine production (Pu et al.,
2016; Sundaram et al., 2016). Cammisotto et al. (2003) could
further find that long chain PUFA suppresses insulin-stimulated
secretion of leptin which is crucial for the regulation of food
intake and maintaining the metabolic homeostasis. This result
was supported by a human study by St-Onge et al. (2014) which
shows that long chain TG consumption instead of medium chain
TG consumption does not reduce food intake by lower rise in
leptin. These results are planned to be outlined in a multicentre
interventional trial to investigate plasma fatty acid changes and
cardiovascular disease risk factors in patients with abdominal
obesity after consumption of different dietary oils (Senanayake
et al., 2014). Recent studies controversially discuss the role of corn
oil supplementation and even recommend replacing saturated
fats by corn oil (Si et al., 2014).
Bohm et al. (2013) postulated in 2013 that food derived
peroxidized fatty acids such as linoleic acid included in WD
with corn oil increases hepatic lipid peroxidation and influences
immune cells and other pro-inflammatory stimuli that trigger
hepatic damage. These findings were corroborated by Takeuchi
et al. (2000) and Slim et al. (1996); finding that corn oil
supplementation increased hepatic cholesterol and TG levels and
activated the oxidative stress response. On the contrary Si et al.
(2014) showed 1 year later that a high corn oil diet improved
health and longevity in mice by lowering serum lipid levels
and decreasing the expression of pro-inflammatory cytokines
such as IL-6, IL-1β or MCP-1. A recent study published by
Ansar et al. (2017) supports this result by demonstrating that
a substitution with corn oil and flaxseed oil reduces fat mass
in HFD fed mice. In line with these results our study also
shows a beneficial effect of dietary supplementation with corn
oil in the WD mouse model compared to the former used
WD-Std. WT mice treated with WD-Corn display less body
weight gain, an improved insulin resistance and decreased serum
lipid levels compared to “standard” trans fat WD (WD-Std)
(Figure 1). Less pronounced steatohepatitis was further reflected
by less histomorphological changes, less hepatic infiltration of
neutrophils (CD11b+/Ly6G+) with simultaneous increase in the
amount of monocytes (CD11b+/F4/80+) tending to secrete a
decreased amount of pro-inflammatory cytokines (IL-6, TNF-α).
This finally resulted in reduced fibrogenesis (Figures 4, 5).
Surprisingly, WD-Corn treatment resulted in an increased
immune cell infiltration and collagen accumulation in epididymal
White Adipose Tissue (eWAT) (Figure 6). Others found in 2012
that lard in HFD also influences adipose tissue inflammation
by regulating adipokine levels giving a direction for future
investigations (Catta-Preta et al., 2012). While the more pro-
inflammatory acting leptin was not changed in eWAT of mice
fed WD-Corn in comparison to WD-Std, adiponectin, which
is known to act in a more anti-inflammatory manner, was
upregulated in eWAT of WD-Corn fed mice (Lopez-Jaramillo
et al., 2014). During formation of metabolic syndrome this may
act in a compensatory way, in which the leptin/adiponectin ratio
and a potential imbalance of both mediators is highly critical.
On the other hand, treating mice with WD supplemented
with a NTF shortening lead to a worsened disease progression
and development compared to trans fat WD (WD-Std) in
all parameters described before. Namely an increase in body
weight, altered insulin resistance, enhanced serum lipid levels,
severe histomorphological changes and increased steatohepatitis
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development (Figures 1–5). Further, a stronger pronounced
progression toward fibrosis is depicted by an increased expression
of inflammatory markers and collagen. Interestingly mice fed
WD-NTF lack any observable changes in eWAT (Figure 6).
Whereat the effects of different fatty acid supplementations
on steatosis development such as corn oil, olive oil, fish oil,
walnut oil and many more were investigated in several different
studies (Belzung et al., 1993; Couet et al., 1997; Flachs et al.,
2006; Lozano et al., 2013; Sain et al., 2013) we could show
for the first time, that the type of supplemented dietary fatty
acids does not influence the lipid composition accumulating
in liver tissue upon steatosis development (Figures 2, 3 and
Supplementary Figure S4).
Taken together, our findings show that WD supplementation
with corn oil shows comparable development and progression
of steatohepatitis as WD-Std, whereas a WD supplemented
with a NTF shortening leads to stronger steatohepatitis
initiation and progression toward fibrosis. These findings
fit perfectly to previous human studies showing that
consuming of trans fats increase the risk of coronary
artery disease by raising levels of low-density lipoprotein,
lowering levels of high-density lipoproteins, and further
increasing total amount of triglycerides, thereby promoting
inflammation, oxidative stress and lipoperoxidation
(Hadj Ahmed et al., 2018). Contrarily, typical corn oils
contain only 0.25 g trans fat/100 g (Song et al., 2015)
and are therefore less toxic and better for the overall
metabolic situation.
Interestingly the type of fat source within the dietary treatment
did not influence the lipid composition accumulating in the
liver. The mixture of NASH-inducing diets available differs a
lot and finding out the exact ingredients of each animal food
with detailed information about the fatty acids composition
is difficult. In this project the manufacturer has helped us
greatly by providing us with the necessary detailed information
(Supplementary Figure S4).
However, we must admit that our study has some limitations.
In particular, the fact that the different WDs we used in our
study still contain some compounds that are not classified in
detail. For example, based on the distributor’s information, the
different WDs (WD-Std, WD-NTF) contain Primex shortening.
This is a mixture of moisture-free, refined and processed
vegetable oils. The exact composition might change from batch
to batch and is chemically not fully defined by each company.
In addition, although power analysis justified the number of
animals used in this study the number incorporated is small.
This however, is in agreement with the actual guidelines of the
new European animal welfare rules which are based on the
3R principle of Russell and Burch (Russell and Burch, 1959)
of Replacement, Reduction and Refinement. This principle for
more ethical use of animals in testing was implemented in
the EU-Directive 2010/63 regarding the protection of animals
used for scientific purposes in 2013 (Liedtke et al., 2013).
Although in our study we only tested n = 4 in each group, our
results show tendencies and statistically significant outcomes.
This was only possible, because our study relied on highly
standardized protocols in which every parameter (daily feed
intake, weight, serum parameters, animal appearance etc.) was
closely monitored. Therefore, we think that the current data
from our study is highly relevant and can be generalized.
Moreover, the study was urgently needed to allow to perform
and compare future animal-based studies that need to be done
without the usage of trans fats which were recently forbidden
by the FDA in all human food products. Therefore, our
study has an important translational character. In this regard,
NAFLD studies using animals relying on WD are highly critical.
There are numbers of comprehensive reviews highlighting this
and other topics (Hansen et al., 2017; Denk et al., 2018;
Jahn et al., 2018).
In sum, WD-NTF and WD-Corn are suitable to replace the
treatment with “standard” WD-Std to investigate steatohepatitis
and fibrosis development and progression in mice.
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FIGURE S1 | Composition WD-NTF. Composition of the used standard Western
diet (WD-Std) (Primex Shortening as fat source) and the WD containing non-trans
fat Primex Shortening as fat source.
FIGURE S2 | Composition WD-Corn. Composition of standard Western diet
(WD-Std) (Primex Shortening as fat source) compared to a WD containing corn
oil as fat source.
FIGURE S3 | Fatty acids composition of WDs. Comparison of the fatty acids
composition of the different Western diets used.
FIGURE S4 | Triglyceride composition. Comparison of TG by mass spectrometry
imaging. Average spectra of animals receiving the WD-Std and WD-Corn show
low variation in absolute peak intensity. The m/z range containing
TG is highlighted.
FIGURE S5 | Oil Red O staining and hepatic triglyceride levels. (A) Representative
images of Oil Red O stained liver sections of WT animals after 24 weeks treatment
with WD-Std, WD-NTF or WD-Corn. Scale bars 100 µm, magnification 200×. (B)
Intrahepatic TG levels were determined in livers of WD-Std, WD-NTF or WD-Corn
fed animals. 4 animals per group were included. (∗p < 0.05, ∗∗ p < 0.01, ∗∗∗
p < 0.001).
FIGURE S6 | NAFLD activity score (NAS). Validation of the NAFLD activity score
(NAS) considering steatosis grade, hepatocellular ballooning, lobular inflammation
and oval cell hyperplasia. The histopathological validation was performed by Prof.
Alain de Bruin at the University of Utrecht.
FIGURE S7 | Immune cell gating strategy. (A) Representative gating of
intrahepatic neutrophils and inflammatory macrophages of WT mice after WD
treatment for 24 weeks. Cells were gated by FSC/SSC, duplets were excluded,
live/dead/CD45+, CD11b+/Ly6G+ (neutrophils), CD11b+/F480+ (inflammatory
macrophages). (B) Depicted is a representative gating of intrahepatic CD4+ and
CD8+ cells in livers of WT animals fed with the different WDs over a 24 weeks time
period. Cells were analyzed by gating on FSC/SSC, live/dead/CD45+,
CD4+/CD8+. Duplets were excluded.
FIGURE S8 | F4/80 and Ly6G staining. (A) Representative images of F4/80
stained liver sections of WT animals. Stainings were performed after 24 weeks of
either chow or WD treatment (WD-Std, WD-NTF, WD-Corn). (Scale bars 100 µm,
magnification 200×). (B) Representative Ly6G stained liver sections of WT mice
after 24 weeks treatment with chow or WD (WD-Std, WD-NTF, WD-Corn) (Scale
bars 100 µm, magnification 200×).
FIGURE S9 | MultiPlex cytokine measurements. (A) MCP-1 or (B) interleukin-18
(IL-18) concentration in livers of WT mice fed with chow or different WDs for
24 weeks (WD-Std, WD-NTF, WD-Corn). Measurement of cytokine levels (n = 4)
were performed with the Mouse serum MultiPlex Cytokine measurements kit
Procarta 9-plex bead assay from Thermo Fisher Scientific (∗p < 0.05).
FIGURE S10 | Leptin and Adiponectin levels in serum, liver and eWAT. (A) Serum,
(B) intrahepatic and (C) eWAT leptin levels were measured in WT mice fed with
different WDs for 24 weeks (WD-Std, WD-NTF, WD-Corn). Measurement of leptin
levels (n = 4) were performed with the Mouse Leptin ELISA Kit from Sabbiotech
(∗p < 0.05; ∗∗p < 0.01). (D) Serum, (E) intrahepatic and (F) eWAT adiponectin
levels were measured in WT mice fed with different WDs for 24 weeks (WD-Std,
WD-NTF, WD-Corn). Measurement of adiponectin levels (n = 4) were performed
with the Mouse Adiponectin ELISA Kit from Rockland (∗p < 0.05; ∗∗ p < 0.01).
TABLE S1 | Primary antibodies for immunofluorescent stainings.
TABLE S2 | Oligonucleotides for real-time PCR analysis.
TABLE S3 | Antibody panel used for FACS analysis.
TABLE S4 | Protein lysis buffer for SDS PAGE.
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